Table 2.
Baseline characteristics of the 27 patients with ankylosing spondylitis.
| DTM group (n = 14) | TM group (n = 13) | p | |
|---|---|---|---|
| Age (years) | 49 (7.78) | 45 (6.71) | 0.351 |
| ESR (mm/h) | 26.1 (8.07) | 27.3 (11.71) | 0.758 |
| CRP (mg/l) | 27.0 (9.41) | 28.9 (12.56) | 0.418 |
| BMI | 27.9 (2.63) | 31.4 (11.64) | 0.394 |
| BASDAI [NRS] | 6.9 (1.45) | 6.7 (0.89) | 0.763 |
| BASFI [NRS] | 6.2 (1.23) | 5.7 (1.56) | 0.274 |
| CE [cm] | 1.6 (0.49) | 1.3 (0.81) | 0.188 |
| MS [cm] | 1.5 (0.83) | 1.7 (1.44) | 0.380 |
| FTF [cm] | 20.56 (9.96) | 19.23 (7.39) | 0.460 |
| PAIN [VAS] | 69.8 (12.51) | 63.3 (10.49) | 0.107 |
|
| |||
| NSAID | 12 | 11 | |
| DMARD synthetic | 9 | 8 | |
| DMARD biologics | 1 | 1 | |
The results are expressed as mean (SD); BMI: body mass index.; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; CE: chest expansion; MS: Modified Schober; FTF: Finger to Floor; PAIN: intensity of lower back pain; NRS: numerical rating scale; VAS: Visual Analog Scale; NSAID: nonsteroidal anti-inflammatory drugs; DMARDs: disease-modifying antirheumatic drugs; p values for differences in the baseline data between the DTM and the TM groups.